Iconiq (Organization): news timeline & CVEs

Meet the next wave of VCs judging Startup Battlefield 200 at TechCrunch Disrupt 2026

TechCrunch names five more venture capitalists judging Startup Battlefield 200 at Disrupt 2026.

TechCrunch announced five more investors who will judge Startup Battlefield 200 at Disrupt 2026 in San Francisco on October 13-15. Founders get six minutes to pitch for a $100,000 prize before judges from ODDBIRD VC, ICONIQ, General Catalyst, IVP, and Eclipse Ventures. The piece is primarily an event promotion and judge biography roundup.

TechCrunch · AIupdated Sep 25, 14:15 UTC · 1d agofirst Sep 24, 16:03 UTC · 2d agoOther 12 sources

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

Enveda raised a $311 million Series E at a $2 billion valuation to advance AI-discovered, nature-derived drugs into trials.

Enveda raised a $311 million Series E at a $2 billion valuation to advance nature-derived drugs discovered with AI. Catalio Capital Management led the round, with Iconiq and others participating, doubling the valuation Enveda reported 12 months earlier. Founded in 2019 by Viswa Colluru, an early Recursion Pharmaceuticals employee, the startup looks for medicines in plants and microbes rather than synthesizing them from scratch. It is already testing candidates in patients for severe skin conditions and for maintaining weight loss after GLP-1 treatment, though no AI-discovered drug has FDA approval yet.

TechCrunch · AISep 23, 19:31 UTC · 3d agoAI industry

Iconiq

Timeline2 articles

Appears with

Meet the next wave of VCs judging Startup Battlefield 200 at TechCrunch Disrupt 2026

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials